HYP focuses on US-listed companies experiencing exceptionally high sales growth or showing signs of entering a hypergrowth phase. The fund defines hypergrowth as year-over-year growth of at least 40% in the current quarter and excludes firms below a set sales threshold. Using a proprietary model, it evaluates liquidity, sales growth, and other performance factors to select and weight holdings without regard to market capitalization. The portfolio typically holds 60 to 80 stocks but can adjust size as needed and rebalances monthly while allowing for longer holding periods when appropriate. Most positions are in US companies, but the fund may invest in non-US companies listed on US exchanges and in ADRs. In unusual circumstances it may use ETFs or cash instruments to manage weights and liquidity. This approach creates a diversified portfolio across sectors centered on companies with rapid growth characteristics.

Applied Opt

AXT Inc

Hewlett Packard Enterprise Co

Dell Technologies Inc

CareDx Inc

AMN Healthcare Services Inc

Penguin Solutions, Inc.

Immunitybio Inc

MaxLinear Inc

Viavi Solutions Inc

Golden Eagle Dynamic Hypergrowth ETF

HYP Holdings & Sector Breakdown